VanEck Pharmaceutical ETF

VanEck Pharmaceutical ETF

PPH

$122.11

Updated: 05/11/2026, 01:23:52

Market Cap
$1.16B
Sector
Financial Services
Industry
Asset Management
Country
US

No historical data available

Company Profile

VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

USD
NASDAQ
https://www.vaneck.com/us/en/investments/pharmaceutical-etf-pph
Asset Summaries
Latest generated summaries for PPH

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for PPH.
Share price
$122.11
Market cap
$1.16B
Exchange
NASDAQ
Currency
USD
CEO
N/A
Employees
N/A
IPO date
01/02/2000
Beta
0.432
Last dividend
$0.00
Day range
$119.59 – $122.15
52-week range
$92.60 – $122.13
1-day performance
2.96%
1-year performance
31.87%
Current drawdown (1Y)
-0.02%
CIK
0001137360
CUSIP
92189F692
ISIN
US92189F6925
Created
07/12/2025, 05:49:16
Last update
05/11/2026, 01:23:52

Track VanEck Pharmaceutical ETF with an AI analyst

See which prediction-market events move PPH, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.